Fatima M Al-Daffaie, Sara F Al-Mudhafar, Aya Alhomsi, Hamadeh Tarazi, Ahmed M Almehdi, Waseem El-Huneidi, Eman Abu-Gharbieh, Yasser Bustanji, Mohammad A Y Alqudah, Ahmad Y Abuhelwa, Adnane Guella, Karem H Alzoubi, Mohammad H Semreen
Prostate cancer (PCa) is a significant global contributor to mortality, predominantly affecting males aged 65 and above. The field of omics has recently gained traction due to its capacity to provide profound insights into the biochemical mechanisms underlying conditions like prostate cancer. This involves the identification and quantification of low-molecular-weight metabolites and proteins acting as crucial biochemical signals for early detection, therapy assessment, and target identification. A spectrum of analytical methods is employed to discern and measure these molecules, revealing their altered biological pathways within diseased contexts...
May 7, 2024: International Journal of Molecular Sciences